Hikma Pharmaceuticals (LSE:HIK)

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.

Related Articles

• Tuesday, 11th June, 2019 | Roland Head

  An overlooked ex-FTSE 100 dividend stock I’d buy and hold forever

  Roland Head explains why he'd buy this former FTSE 100 (INDEXFTSE: UKX) stock, despite its recent demotion to the FTSE 250. Read More »

• Saturday, 1st June, 2019 | The Motley Fool Staff

  Top shares for June 2019

  We asked our freelance writers to share their top stock picks for the month. Read More »

• Friday, 17th May, 2019 | Kevin Godbold

  Why I’d snap up this FTSE 100 pharmaceutical provider alongside GlaxoSmithKline

  I like GlaxoSmithKline plc (LON: GSK), but I also think today’s update from this smaller FTSE 100 (INDEXFTSE: UKX) competitor is encouraging. Read More »

• Monday, 22nd April, 2019 | Kevin Godbold

  3 FTSE 100 shares I’d snap up for my Stocks and Shares ISA

  The FTSE 100 index (INDEXFTSE: UKX) is packed with great shares and here are three that I like. Read More »

• Tuesday, 19th March, 2019 | Roland Head

  2 dividend stocks I’d buy for an ISA today

  These dividend stocks could be big winners over the next decade, says Roland Head. Read More »

• Wednesday, 13th March, 2019 | G A Chester

  Could this FTSE 100 stock double your money again?

  G A Chester discusses the outlook for this FTSE 100 (INDEXFTSE:UKX) big winner and a smaller-cap peer. Read More »

• Wednesday, 27th February, 2019 | Peter Stephens

  Forget Bitcoin! I think buying these 2 pharma stocks could be a better way to get rich

  The healthcare segment may offer a stronger growth outlook than the virtual currency due to demographic change. Read More »

• Monday, 14th January, 2019 | Harvey Jones

  I think these 2 fast-recovering FTSE 250 pharma growth stocks could make you richer

  Harvey Jones says these two FTSE 250 (INDEXFTSE: MCX) stocks are in fine form after a sickly year. Read More »

• Monday, 24th December, 2018 | Alan Oscroft

  Can this year’s biggest FTSE 250 winners keep it going in 2019?

  2018 has been a great year for the top FTSE 250 (INDEXFTSE: MCX) stocks. Will 2019 see their strong run continuing? Read More »

• Thursday, 8th November, 2018 | Peter Stephens

  The BT share price soars by 20%. Here’s why I think it could beat the FTSE 100

  BT Group plc (LON: BT.A) could offer further growth potential versus the FTSE 100 (INDEXFTSE:UKX). Read More »